VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TBI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TBITrueBlue, Inc.
$7.22$219M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

TBI logoTrueBlue, Inc.(TBI)Earnings, Financials & Key Ratios

TBI•NYSE
$7.22
Price updated Jul 6, 2026
SectorIndustrialsIndustryStaffing & HRSub-IndustryOutsourced Recruitment and Workforce Management
AboutTrueBlue, Inc., together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The PeopleReady segment offers contingent staffing solutions for blue-collar, on-demand, and skilled labor in construction, manufacturing and logistics, warehousing and distribution, waste and recycling, energy, retail, hospitality, and general labor industries. The PeopleManagement segment provides contingent labor and outsourced industrial workforce solutions. This segment also offers on-site management and recruitment for the contingent industrial workforce of manufacturing, warehouse, and distribution facilities; and recruitment and management of contingent and dedicated commercial drivers to the transportation and distribution industries under the Staff Management, SIMOS Insourcing Solutions, and Centerline Drivers brands. The PeopleScout segment offers permanent employee recruitment process outsourcing services; and manages clients' contingent labor programs comprising vendor selection, performance management, compliance monitoring, and risk management. The company was formerly known as Labor Ready, Inc. and changed its name to TrueBlue, Inc. in December 2007. TrueBlue, Inc. was incorporated in 1985 and is headquartered in Tacoma, Washington.Show more
  • Revenue$1.62B+3.1%
  • EBITDA$2M+103.2%
  • Net Income-$48M+61.9%
  • EPS (Diluted)-1.61+61.4%
  • Gross Margin21.23%-18.1%
  • EBITDA Margin0.13%+103.1%
  • Operating Margin-1.66%+72.0%
  • Net Margin-2.97%+63.0%
  • ROE-16.26%+50.0%

TBI Price & Volume

TrueBlue, Inc. (TBI) stock price & volume — 10-year historical chart

Loading chart...

Persistent Operating Losses Threaten TrueBlue Capital Stability

Investment Thesis • Updated 2026Q1

VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Strained
Cash Flow:Burning
Primary Risk:Persistent Operating Margin Deficit

Key Thesis Takeaways

  • TrueBlue faces a challenging structural outlook as it struggles to reconcile rigid SG&A expenses with a contracting revenue base, which plummeted to a 100% decline in 2026Q1.
  • The company's inability to achieve positive operating leverage, evidenced by a -2.8% operating margin in 2025Q4, suggests significant headwinds in its core industrial staffing segments.
  • Investors should remain cautious as the erosion of the equity base from $457.9 million in 2023Q4 to $256.1 million in 2026Q1 highlights a precarious path toward long-term solvency.

Verdict Logic

the company's inability to generate positive free cash flow, combined with a dwindling cash position of $24.1 million as of 2026Q1, presents an elevated risk of further balance sheet erosion.

TBI Growth Metrics

TrueBlue, Inc. (TBI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-4.99%
5 Years-2.63%
3 Years-10.5%
TTM-18.83%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM61.41%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM61.01%

Return on Capital

10 Years-0.43%
5 Years-1.07%
3 Years-7.95%
Last Year-5.28%

TBI Recent Earnings

TrueBlue, Inc. (TBI) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 5, 2026
Metric
Actual
Est
EPS
$0.41+8.9%
$0.45
Rev
$399M+2.1%
$391M
Q1 2026
Feb 18, 2026
Metric
Actual
Est
EPS
$0.25-212.5%
$0.08
Rev
$418M+0.9%
$415M
Q4 2025
Nov 3, 2025
Metric
Actual
Est
EPS
$0.03+133.3%
$0.09
Rev
$431M+4.3%
$413M
Q3 2025
Aug 4, 2025
Metric
Actual
Est
EPS
$0.07+77.4%
$0.31
Rev
$396M-0.6%
$399M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$0.41vs $0.45+8.9%
$399Mvs $391M+2.1%
Q1 2026Feb 18, 2026
$0.25vs $0.08-212.5%
$418Mvs $415M+0.9%
Q4 2025Nov 3, 2025
$0.03vs $0.09+133.3%
$431Mvs $413M+4.3%
Q3 2025Aug 4, 2025
$0.07vs $0.31+77.4%
$396Mvs $399M-0.6%
Based on last 12 quarters of dataView full earnings history →

Latest TBI News

Recent stock market news and headlines for TrueBlue, Inc. (TBI)

Business Wire·Jun 23, 2026
Hope Biosciences Reports Positive Published Clinical Data Following Stem Cell Therapy in Chronic Traumatic Brain Injury

HOUSTON--(BUSINESS WIRE)-- #biopharma--For millions of people living with the long-term effects of traumatic brain injury (TBI), the prevailing belief has been that chronic neuroinflammation causes recovery to plateau over time, meaning correspondingly few long-range care options. New research published in the prestigious journal Brain, one of the world's leading neurology journals, is challenging that assumption. “Our findings suggest that chronic neuroinflammation may be a treatable target, even years aft.

Peers Comparison

Key metrics vs top competitors for TrueBlue, Inc. (TBI)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
TBI logoTBITrueBlue, Inc.Current
$7.22$219.2M-4.483.1%-2.97%-16.26%—
MAN logoMANManpowerGroup Inc.
$38.44$1.79B-132.550.58%-0.09%-0.81%—
KFY logoKFYKorn Ferry
$71.10$3.62B13.626.43%9.44%14.16%—
KELYA logoKELYAKelly Services, Inc.
$12.96$449.31M-1.79-1.87%-6.44%-24.58%—
HSII logoHSIIHeidrick & Struggles International, Inc.
$59.01$1.23B143.937.15%3.05%7.28%—
ASGN logoASGNASGN Incorporated
$20.96$894.99M8.06-2.91%2.85%6.26%—

Compare TBI vs Peers

TrueBlue, Inc. (TBI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs MAN

Most directly comparable listed peer for TBI.

Scale Benchmark

vs ADP

Larger-name benchmark to compare TBI against a more recognizable public peer.

Peer Set

Compare Top 5

vs MAN, KFY, KELYA, HSII

TBI SEC Filings & Documents

TrueBlue, Inc. (TBI) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 6, 2026·SEC

Material company update

May 5, 2026·SEC

Material company update

Apr 13, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 18, 2026·SEC

FY 2025

Feb 19, 2025·SEC

FY 2024

Feb 21, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 5, 2026·SEC

FY 2025

Nov 3, 2025·SEC

FY 2025

Aug 4, 2025·SEC

Get notified when TBI posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

TBI Frequently Asked Questions

TrueBlue, Inc. (TBI) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is TrueBlue, Inc.'s revenue?

TrueBlue, Inc. (TBI) reported $1.25B in revenue for fiscal year 2025. This represents a 662% increase from $163.5M in 1996.

How fast is TrueBlue, Inc. growing?

TrueBlue, Inc. (TBI) grew revenue by 3.1% over the past year. Growth has been modest.

Is TBI profitable?

TrueBlue, Inc. (TBI) reported a net loss of $53.4M for fiscal year 2025.

Dividend & Returns
What is TBI's return on equity?

TrueBlue, Inc. (TBI) has a return on equity (ROE) of -16.3%. Negative ROE indicates the company is unprofitable.

What is TrueBlue, Inc.'s free cash flow?

TrueBlue, Inc. (TBI) had negative free cash flow of $59.5M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in TBI back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →